** Australian healthcare stocks .AXHJ slip 1.2% to a one-week low, extending declines from previous session
** Vaccine maker CSL CSL.AX down 1.8%; biopharma Telix TLX.AX drops 3.3%
** US President Trump signs executive order aiming to reduce approval time for local pharma plants to encourage domestic manufacturing; plans pharma tariffs in next two weeks
** Australian healthcare firms largely depend on exports to the U.S. and are hurt by a strong Australian dollar, which has hit a new five-month peak. AUD/
(Reporting by Sneha Kumar in Bengaluru)
((Sneha.kumar@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.